Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...

Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people ...

People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

Study suggests inability to identify blood in urine may delay diagnosis and reduce surviva ...

People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

Out of sight, out of mind. A new study suggests a common eye condition could be quietly masking one of the only early warning signs of bladder cancer — the 10th leading cause of cancer deaths in the ...

When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.

On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.